iBio (IBIO) Depreciation & Amortization (CF) (2010 - 2026)
iBio's (IBIO) quarterly Depreciation & Amortization (CF) came in at $147000.0 in Q1 2026, up 21.49% year-on-year from $121000.0 in Q1 2025, and up 4.26% on a QoQ basis from $141000.0 in Q4 2025.
iBio (IBIO) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
iBio (IBIO) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $147000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 21.49% year-over-year to $147000.0 in Q1 2026; TTM through Mar 2026 was $532000.0, a 4.52% increase from a year earlier, with the FY2025 full-year figure at $484000.0, down 24.14% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $147000.0, up from $141000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for IBIO reached as high as $743000.0 in Q2 2022 and fell as low as $120000.0 in Q3 2024.
- Historically, Depreciation & Amortization (CF) has averaged $237923.1 across 5 years, with a median of $146000.0 in 2024.
- Across the five-year window, Depreciation & Amortization (CF) jumped 495.8% in 2022 and plunged 39.11% in 2023, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $271000.0 in 2022, then sank by 39.48% to $164000.0 in 2023, then decreased by 25.61% to $122000.0 in 2024, then advanced by 15.57% to $141000.0 in 2025, then advanced by 4.26% to $147000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $147000.0 in Q1 2026, $141000.0 in Q4 2025, and $123000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 147,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147,000.00 |
| Mar 31, 2026 | 147,000.00 |
| Dec 31, 2025 | 141,000.00 |
| Dec 31, 2025 | 141,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 121,000.00 |
| Jun 30, 2025 | 121,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Dec 31, 2023 | 164,000.00 |
| Dec 31, 2023 | 164,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Sep 30, 2023 | 165,000.00 |